Speaker(s): 

M. Amer Swid, MD, Resident Physician, Geisinger - has nothing to disclose.

Haluk Kavus, MD, Resident Physician, Geisinger - has nothing to disclose.

Moderator(s): 

Zachary Hoffer, MD, Pathology Residency Program Director, Geisinger - has nothing to disclose. 

Learning Objectives: 

At the conclusion of this session, the participant should be able to: 

• Describe the influence of patient population, type of approach (USG versus palpation-guided), and the personnel performing the procedure (radiologist versus pathologist) on the diagnostic results of FNAs of salivary glands
• Demonstrate the utility of the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) in conjunction with ultrasound guidance (USG) and ROSE in a cancer center setting, particularly in the context of cysts with non-mucinous contents
• Identify Transient abnormal myelopoiesis (TAM) in Down syndrome patients
• Identify the underlying molecular driver mutations of progression of TAM to myeloid neoplasm in Down syndrome patients

Disclosure of Relevant Financial Relationships with/without Commercial Interests:

The Planning Committee consisting of Zachary S. Hoffer, MD have no identified disclosures. 

CE Committee Member/Content Reviewers have nothing to disclose. 

Any/All relevant financial relationships have been mitigated. 

Content Disclosure: 

This presentation/content is HIPPA compliant. 

Commerical Support for this Session: 

None.